肿瘤坏死因子相关凋亡诱导配体(TRAIL)是肿瘤坏死因子(TNF)超家族成员之一,能选择性的诱导肿瘤细胞、转化细胞凋亡,而对正常组织无毒性,有望成为肿瘤治疗的新方法,备受人们的关注。本文从TRAIL的结构、受体、诱导肿瘤细胞凋亡机制及在肿瘤治疗中的应用等方面作了介绍,以期为TRAIL临床应用提供参考。
Tumor necrosis factor(TNF)-related apoptosis-inducing ligand(TRAIL) is a member of TNF superfamily,which could selectively induce apoptosis in numerous tumor cell lines.And it is non-toxic in normal cells.TRIAL may be a new method of cancer therapy,thus it has spurred our attention.This review introduces research progress in TRAIL from several aspects:structure,receptor,the pathway of inducing apoptosis and the applications in cancer therapy,which is expected to be helpful in cancer treatment by TRAIL.